Articles by: David Fisher

Novartis to Sell US Derma Business, Oral Solids Portfolio to Aurobindo for Up to $1 Billion

September 6, 2018 at 8:54 am

Swiss drugmaker Novartis (NOVN.SW, NVS) has agreed to sell portions of its Sandoz US portfolio to Aurobindo Pharma USA for up to $1 billion as it seeks to focus the Sandoz division on higher growth areas. The company said on Thursday that it will divest the Sandoz US dermatology business and generic US oral solids portfolio to Aurobindo Pharma USARead More